Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000395

Drug Information
NamePegfilgrastim    
SynonymsNeulasta (TN); 208265-92-3; D06889; Pegfilgrastim (INN); Neulasta; Pegfilgrastim    
Trade NameNeulasta    
CompanyAmgen Inc    
IndicationNon-myeloid cancerApproved    [1]
Therapeutic ClassImmunomodulatory Agents    
CAS NumberCAS 208265-92-3
FormularC845H1343N223O243S9    
PubChem Substance IDSID 49661789.    
TargetMacrophage colony-stimulating factor receptorBinder[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Evidence that the granulocyte colony-stimulating factor (G-CSF) receptor plays a role in the pharmacokinetics of G-CSF and PegG-CSF using a G-CSF-R KO model. Pharmacol Res. 2004 Jul;50(1):55-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543